Sage Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	3.85	4.15	5.38	4.22	2.19	1.99
Revenue Growth (YoY)	-23.45%	-22.80%	27.33%	92.69%	10.38%	-
Cost of Revenue	3.65	4.13	6.99	6.22	3.01	3.37
Gross Profit	0.19	0.02	-1.61	-1.99	-0.82	-1.38
Selling, General & Admin	1.03	1.14	1.31	2.17	0.36	0.64
Other Operating Expenses	-0.26	0.29	-0.06	-0.22	-0.32	-0.1
Operating Expenses	2.34	2.91	2.6	2.81	0.44	0.91
Operating Income	-2.14	-2.89	-4.21	-4.8	-1.26	-2.29
Interest Expense	-0.07	-0.08	-0.04	-0.73	-0.04	-0.09
Currency Exchange Gain (Loss)	-0	-0	0.14	0.46	0.03	-0.01
Other Non Operating Income (Expenses)	-0.04	-0.04	-0.06	-0.01	-0.02	-0.02
EBT Excluding Unusual Items	-2.25	-3.01	-4.17	-5.09	-1.29	-2.41
Other Unusual Items	0.02	0.02	0.28	-	0.29	0.09
Pretax Income	-2.24	-2.99	-3.89	-5.09	-1	-2.32
Net Income	-2.24	-2.99	-3.89	-5.09	-1	-2.32
Net Income to Common	-2.24	-2.99	-3.89	-5.09	-1	-2.32
Shares Outstanding (Basic)	1	1	1	1	1	1
Shares Outstanding (Diluted)	1	1	1	1	1	1
Shares Change (YoY)	18.61%	23.28%	2.28%	10.72%	4.21%	-
EPS (Basic)	-1.69	-2.30	-3.69	-4.94	-1.07	-2.60
EPS (Diluted)	-1.69	-2.30	-3.69	-4.94	-1.07	-2.60
Free Cash Flow	-0.7	-1.11	-2.26	-4.63	-0.5	-1.49
Free Cash Flow Per Share	-0.53	-0.86	-2.15	-4.49	-0.54	-1.66
Gross Margin	5.05%	0.52%	-29.94%	-47.24%	-37.40%	-69.66%
Operating Margin	-55.66%	-69.59%	-78.30%	-113.75%	-57.55%	-115.28%
Profit Margin	-58.09%	-71.99%	-72.38%	-120.55%	-45.44%	-116.95%
Free Cash Flow Margin	-18.13%	-26.81%	-42.09%	-109.66%	-23.04%	-74.85%
EBITDA	-1.63	-2.47	-3.6	-3.95	-0.9	-1.94
EBITDA Margin	-42.43%	-59.56%	-66.86%	-93.56%	-41.00%	-97.77%
D&A For EBITDA	0.51	0.42	0.61	0.85	0.36	0.35
EBIT	-2.14	-2.89	-4.21	-4.8	-1.26	-2.29
EBIT Margin	-55.66%	-69.59%	-78.30%	-113.75%	-57.55%	-115.28%
Advertising Expenses	-	-	-	-	0.07	0.27

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q